FDA Advisory No.2023-1881 || Pilot Implementation of the Food and Drug Administration Customer Relation Management Information System (CRMIS)
The Food and Drug Administration (FDA), as mandated by Republic Act No. 9711 otherwise known as the “FDA Act of 2009”, in the development of information technology infrastructures and its […]
FDA Advisory No.2023-1092 || Schedule of Acceptance for Antibiotic Batch Notification Representative Sample and Required Document/s (Post-Submission)
To ensure efficient processing of antibiotic batch notification and secure the integrity of representative sample and required document/s during post-submission, the Food and Drug Administration (FDA) through the Common Services […]
FDA Advisory No.2023-0765 || Engagement with Consultancy Firms to Transact Business with the Food and Drug Administration
The FDA is aware that there are several companies or individuals offering services related to FDA regulations such as assisting with product approvals or providing advice on regulatory compliance. However, […]
FDA Advisory No.2023-0518 || Operating Periods of FDA Online Services
The Food and Drug Administration (FDA) is currently undergoing system maintenance and upgrade. We understand that this may cause inconvenience, but this upgrade is necessary to improve the efficiency and […]
FDA Advisory No.2023-0407-A || Hindi Awtorisadong Paggamit ng DOH at FDA Logo sa Pagrerekomenda ng Produktong Pangkalusugan
Naipaabot sa kaalaman ng aming ahensya ang “Public Health Recommendation” na nakalagay sa isang social media platform na nagsasaad na inirerekomenda ng FDA ang naturang produktong pangkalusugan. Nais paalalahanan ang […]
FDA Advisory No.2023-0407 || Unauthorized use of the DOH and FDA Logo in the Recommendation of a Health Product
Our office received a report that a certain “Public Health Recommendation” with an unauthorized use of the Department of Health (DOH) and the Food and Drug Administration (FDA) logo was […]
FDA Advisory No.2023-0312 || External Communications for the Food and Drug Administration
Due to the influx of communications and transactions with improper designation and erroneous address, the Food and Drug Administration Action Center (FDAC) has been encountering delays in the processing of […]
FDA Advisory No.2023-0258 || Implementation of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) Guide for Good Manufacturing Practice (GMP) for Medicinal Products in Compliance with DOH Administrative Order No. 2012-0008
This is in compliance with Administrative Order No. 2012-0008 (AO 2012-0008), or the rules on “Adoption and Implementation of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) Guide for Good Manufacturing Practice […]
FDA Advisory No.2023-0165 || INTEGRATION OF LANDBANK LINK.BIZPORTAL TO THE FDA ESERVICES PORTAL
The Food and Drug Administration (FDA), in its commitment to provide effective and efficient public health service delivery, has integrated the Landbank Link.BizPortal Online Payment Gateway System to the FDA […]
FDA Advisory No.2022-1621 || Health Guidelines and Precautions for Meeting Requests with the Office of the Director General
In response to the continuing threat of the COVID-19 pandemic, the following guidelines are to be complied with by all non-FDA personnel who wish to arrange for a meeting with […]